Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often treated cosmetically or with hormone therapy if contraception is also desired.

Estrogens can reduce DHT production in hair follicles, but are less effective than finasteride and progesterone.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Knee laxity varies with menstrual cycle phases, being highest during ovulation and menstruation, and is influenced by sex-steroids.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Interval training is better for heart and metabolic health in reproductive-aged females than regular moderate exercise.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Steers with winter hair coats and reduced sweating struggled with heat, leading to less grazing and poor performance.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.

Hormonal contraception can improve acne and excess hair growth, enhancing women's quality of life.

Testosterone metabolites may help relieve diabetic nerve pain.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.